<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(1)</volume><submitter>Xie R</submitter><funding>Special Research Fund for Traditional Chinese Medicine Science and Technology of Guangdong Provincial Hospital of Chinese Medicine</funding><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Tension-type headache (TTH) is the most prevalent neurological disease, with an estimated 1.5 billion cases worldwide. Pharmacotherapy should be considered by patients with TTH who have a limited response to non-pharmacological treatment. However, recommendations for the vast array of therapeutic drugs for TTH partially overlap, with conflicting recommendations for strength in different guidelines; these may confuse the decision-making process of clinicians. Hence, the aims of this study are to analyse the available direct and indirect evidence on different drug monotherapies for TTH in adults, and to generate a treatment ranking according to their efficacy and safety outcomes by using a Bayesian network meta-analysis (NMA).&lt;h4>Methods and analysis&lt;/h4>We will systemat</pubmed_abstract><journal>BMJ open</journal><pagination>e023748</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6340443</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Efficacy and safety of different drug monotherapies for tension-type headache in adults: study protocol for a Bayesian network meta-analysis.</pubmed_title><pmcid>PMC6340443</pmcid><pubmed_authors>Tian J</pubmed_authors><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Cai Y</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Xie R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Efficacy and safety of different drug monotherapies for tension-type headache in adults: study protocol for a Bayesian network meta-analysis.</name><description>&lt;h4>Introduction&lt;/h4>Tension-type headache (TTH) is the most prevalent neurological disease, with an estimated 1.5 billion cases worldwide. Pharmacotherapy should be considered by patients with TTH who have a limited response to non-pharmacological treatment. However, recommendations for the vast array of therapeutic drugs for TTH partially overlap, with conflicting recommendations for strength in different guidelines; these may confuse the decision-making process of clinicians. Hence, the aims of this study are to analyse the available direct and indirect evidence on different drug monotherapies for TTH in adults, and to generate a treatment ranking according to their efficacy and safety outcomes by using a Bayesian network meta-analysis (NMA).&lt;h4>Methods and analysis&lt;/h4>We will systemat</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jan</publication><modification>2025-04-26T15:39:09.266Z</modification><creation>2019-03-26T22:47:38Z</creation></dates><accession>S-EPMC6340443</accession><cross_references><pubmed>30647037</pubmed><doi>10.1136/bmjopen-2018-023748</doi></cross_references></HashMap>